U.S. Senators Urge FDA Update to Mifepristone Label for Miscarriage Use: 'Patients Should Have Access to the Most Effective Medication Available'

U.S. Senators Urge FDA Update to Mifepristone Label for Miscarriage Use: ‘Patients Should Have Access to the Most Effective Medication Available’

For years doctors have prescribed mifepristone off label for miscarriage treatment, a practice allowable by the FDA. But now, new state bans and restrictions on medication abortion has raised concerns that prescribing mifepristone could lead to criminal prosecution of healthcare providers. Reproductive health advocates are now urging the FDA to specifically label mifepristone for miscarriage treatment.

“Patients experiencing an early miscarriage should have access to the most effective medication available.”